Evotec partners X-Chem for tech-enabled drug discovery [Yahoo! Finance]
CLARIANT AG UNSP/ADR (CLZNY)
NASDAQ:AMEX Investor Relations:
clariant.com/en/investors
Company Research
Source: Yahoo! Finance
This approach will aid in enhancing the efficiency and precision of identifying potential drug candidates. X-Chem CEO Karen Lackey stated: “Partnerships to access best-in-class platforms are the way forward to address the complexity in drug discovery. The partnership comes as Evotec is undergoing an accelerated transformation programme to address a challenging market environment. Despite plans to cut 400 jobs, the company's CEO Christian Wojczewski announced cost-saving measures aimed at generating savings of at least €40m ($44m) in 2024/25. Evotec is also optimistic about the future, with revenue projections for the financial year 2024 (FY 2024) showing a slight increase from €790m to €820m, compared to €781m in FY 2023. "Evotec partners X-Chem for tech-enabled drug discovery" was originally created and published by Pharmaceutical Technology , a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It
Show less
Read more
Impact Snapshot
Event Time:
CLZNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLZNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLZNY alerts
High impacting CLARIANT AG UNSP/ADR news events
Weekly update
A roundup of the hottest topics
CLZNY
News
- Shareholders in Clariant (VTX:CLN) have lost 26%, as stock drops 4.2% this past week [Yahoo! Finance]Yahoo! Finance
- Ben van Beurden proposed as new Chairman and Member of the Board of Directors of Clariant AG [Yahoo! Finance]Yahoo! Finance
- Clariant AG's (VTX:CLN) top owners are individual investors with 36% stake, while 32% is held by public companies [Yahoo! Finance]Yahoo! Finance
- 3 Stocks On The SIX Swiss Exchange Estimated To Be Up To 43.3% Below Intrinsic Value [Yahoo! Finance]Yahoo! Finance
- 3 Swiss Stocks On SIX Swiss Exchange Trading At Up To 42.8% Estimated Discount [Yahoo! Finance]Yahoo! Finance